Why the study?
Does pre-discharge NT-proBNP predict adverse prognosis better than admission NT-proBNP in patients hospitalized with acute LVF?
Population
96 patients hospitalized with acute left ventricular failure (LVF)
Comparison
Pre-discharge plasma NT-proBNP measurement vs Admission plasma NT-proBNP measurement
Design
Cohort
Follow-up
median 350 days (range 2-762)
Authors
Loading...
May aid discharge risk stratification in acute LVF; extends observational data but leaves open prospective validation.
Does pre-discharge NT-proBNP predict adverse prognosis better than admission NT-proBNP in patients hospitalized with acute LVF?
Pre-discharge NT-proBNP is a superior prognostic marker compared to admission NT-proBNP for predicting death or recurrent heart failure in patients hospitalized with acute left ventricular failure.
O’Brien et al. (2003) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: